Figure 2From: Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success Patients with sinus rhythm after undergoing CABG, aortic valve disease and combined cardiac surgery at discharge, 6 and 12 months follow-up.Back to article page